PreveCeutical signs Research and Option Agreement with UniQuest Pty Limited for Developing Dual-Gene Therapy Treatment for Diabetes and Obesity VANCOUVER, British Columbia, July 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”)  (CSE:PREV) announces, further to its news release dated April 13, 2017,...